Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Merck & Co. Inc. buy Barclays PLC

Start price
€103.20
21.02.26 / 50%
Target price
-
21.02.27
Performance (%)
0.19%
Price
€103.40
11:48
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Merck & Co. Inc. is nearly unchanged. This prediction currently runs until 21.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w
Merck & Co. Inc. -0.385%
iShares Core DAX® -3.809%
iShares Nasdaq 100 0.487%
iShares Nikkei 225® -4.418%
iShares S&P 500 0.251%

Comments by Barclays_PLC for this prediction

In the thread Merck & Co. Inc. diskutieren

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat

Stopped prediction by Barclays_PLC for Merck & Co. Inc.

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€103.80
20.02.26
€119.08
20.02.27
-0.39%
11:48

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€98.90
07.10.24
€127.58
07.10.25
-23.46%
08.10.25

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€104.60
31.07.24
€131.14
31.07.25
-34.80%
01.08.25

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€116.60
02.02.24
€134.11
02.02.25
-18.18%
03.02.25

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€108.20
23.01.24
€124.16
23.01.25
-14.23%
24.01.25